6C4F.70 Mood disorder induced by multiple specified psychoactive substances International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 Mood disorder induced by multiple specified psychoactive substances is characterised by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxication with or withdrawal from multiple specified psychoactive substances. The intensity or duration of the symptoms is substantially in excess of mood disturbances that are characteristic of intoxication with or withdrawal from multiple specified psychoactive substances. The amount and duration of use of the multiple specified psychoactive substances must be capable of producing mood symptoms. The symptoms are not better explained by a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the mood symptoms preceded the onset of the use of the multiple specified psychoactive substances, if the symptoms persist for a substantial period of time after cessation of the use of the multiple specified psychoactive substances or withdrawal from the multiple specified psychoactive substances, or if there is other evidence of a pre-existing primary mental disorder with mood symptoms (e.g., a history of prior episodes not associated with the use of the multiple specified psychoactive substances).
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Medication - multiple selections are allowed [select] XM2PL7 Cannabinoids – XM3UF9 Nabilone – XM4HM2 Tetrahydrocannabinol – XM5B55 Cannabidiol – XM1W83 Dronabinol XM4SV9 Hallucinogens – XM5JH5 Psilocin – XM7642 Psilocybin – XM0T53 Mescaline – XM78V1 Aeruginascin – XM9WX3 Bufotenine – XM9T61 N,N-Dimethyltryptamine – XM9CL3 Lysergic acid amide – XM5M84 Phencyclidine – XM50E4 Muscimol – XM1PJ8 Ibotenic acid – XM5SB5 Salvinorin A –– XM3C53 Amfetaminil –– XM3E65 Benzedrine (amphetamine) –– XM1NA8 Central nervous system stimulants amphetamines –– XM1WW4 Dexedrine –– XM6LD5 Dextroamphetamine –– XM07Y4 Ecstasy –– XM5B49 Methamphetamine –– XM3WD9 Methedrine –– XM3Q37 Methylamphetamine ––– XM9932 Psychostimulant caffeine –– XM6RB6 Psychostimulant amphetamine –– XM6V10 Tenamfetamine XM12M9 Psychostimulants, ADHD and nootropic agents – XM7LR7 Centrally acting sympathomimetics –– XM1NX2 Methylphenidate –– XM52S5 Pemoline –– XM75Z6 Modafinil –– XM5921 Fenozolone –– XM9DQ5 Atomoxetine –– XM5288 Dexmethylphenidate –– XM3ZW9 Armodafinil –– XM9FY1 Etryptamine –– XM3K58 Levopropylhexedrine – XM2XU4 Xanthine derivatives –– XM0NG8 Caffeine –– XM3Y68 Propentofylline – XM1SE2 Meclofenoxate – XM8QG2 Nizofenone – XM84X9 Prolintane – XM8EX0 Pipradrol – XM8029 Vinpocetine – XM37E2 Tipepidine – XM1LB1 Pyritinol – XM5207 Piracetam – XM3HZ4 Deanol – XM2AB6 Fipexide – XM5TT1 Citicoline – XM5N75 Oxiracetam – XM6EM2 Pirisudanol – XM1MZ1 Linopirdine – XM0Z60 Aniracetam – XM77H2 Acetylcarnitine – XM5CY6 Idebenone – XM59Z4 Pramiracetam – XM3WZ9 Adrafinil – XM94C0 Mebicar – XM3J14 Phenibut – XM45U3 Deanol aceglumate – XM9DQ3 Diethyltryptamine (DET) – XM6LV4 Dimethyl tryptamine – XM9438 Hawaiian Woodrose seeds – XM52J2 Heavenly Blue (morning glory) – XM79N5 Magic mushroom – XM0169 Mescal buttons – XM32H5 Morning glory seeds – XM4B51 Pearly Gates (morning glory seeds) – XM0QA2 Peyote – XM0075 Yohimbic acid – XM8E16 Cannabinol – XM0XQ5 Central nervous system depressants hallucinogenics – XM31A7 Psychodysleptic drug – XM3Z58 Psychotomimetic agents – XM8X97 Hallucinogen – XM7DW4 Megahallucinogen –– XM3473 Hydromorphinol –– XM8SD7 Hydromorphone –– XM78E0 Metopon –– XM7VL7 Morpholinylethylmorphine –– XM7W06 Nicomorphine –– XM9BE3 Normorphine –– XM64M0 Oxymorphone –– XM1KZ5 Morphine –– XM0P98 Benzylmorphine –– XM7ZJ1 Myrophine – XM4ES0 Opium –– XM2T93 Opium alkaloids (total) –– XM69X3 Opium alkaloids standardized powdered –– XM91H1 Opium alkaloids tincture (camphorated) –– XM1EE2 Laudanum –– XM1YK2 Papaveretum –– XM1LB8 Paregoric – XM4SL9 Oxycodone –– XM79K2 Acetyldihydrocodeinone –– XM7HX3 Eucodal – XM9UH3 Nalfurafine – XM4587 Codeine, codeine derivatives and other opioids used in cough suppression –– XM3DS6 Acetyldihydrocodeine –– XM05R0 Antitussive codeine mixture –– XM3YP8 Cliradon –– XM4046 Desocodeine –– XM06K5 Dihydrocodeine –– XM77C9 Dihydroisocodeine –– XM9UN6 Hycodan –– XM0YG5 Hydroxydihydrocodeinone –– XM07U7 Percodan –– XM5NP7 Piminodine –– XM3WN9 Ethylmorphine –– XM8E09 Hydrocodone –– XM6RX7 Noscapine –– XM4QV7 Pholcodine –– XM9UV0 Dextromethorphan –– XM2358 Thebacon –– XM7V96 Dimemorfan –– XM5PZ4 Normethadone – XM1ZY9 Methadone, methadone derivatives and other drugs used to treat opioid addictive disorders –– XM7XP1 Methadone ––– XM9RG7 Levo-iso-methadone – XM4MV8 Opioid anaesthetics –– XM4G88 Alfentanil –– XM1EF3 Sufentanil –– XM7YQ6 Anileridine –– XM0YQ0 Remifentanil –– XM7TT0 Antagonist narcotic analgesic –– XM0850 Cyclazocine –– XM65J2 Levallorphan –– XM4HP3 Morphine antagonist –– XM14T9 Naloxone –– XM2M16 Naltrexone –– XM9BM4 Narcotic antagonist –– XM5DJ2 Opiate antagonists –– XM3TK0 Methylnaltrexone bromide –– XM4GP3 Alvimopan –– XM93Z3 Naloxegol –– XM6KY8 Opioid antagonist – XM4S22 Other opioid analgesics, natural, synthetic and semi-synthetic –– XM30T6 Prodine –– XM9907 Antitussive opiate –– XM6C31 Cough mixture containing opiates –– XM8ZF5 Dextrorphan –– XM1K75 Difencloxazine –– XM1HE9 Dilaudid –– XM9SW6 Dipipanone –– XM81P5 Dromoran –– XM4EW3 Eptazocine –– XM6CK0 Ethoheptazine –– XM35C1 Heptalgin –– XM5F21 Levo-dromoran –– XM4P40 Levopropoxyphene –– XM1R71 Levorphanol –– XM0GS3 Meperidine –– XM8PP7 Narcotic synthetic –– XM8MP5 Nisentil –– XM7S23 Opioid –– XM04Z5 Phenadoxone –– XM2542 Phenazocine –– XM9B34 Phenomorphan –– XM72D5 Pipadone –– XM39L3 Profadol –– XM9AZ5 Promedol –– XM3E08 Propoxyphene –– XM6625 Racemoramide –– XM8804 Thebaine –– XM09H6 Tilidine –– XM7KC0 Tramadol –– XM5UK3 Viminol –– XM9Y28 Diphenoxylate –– XM86N4 Loperamide –– XM9NL3 Phenylpiperidine derivatives ––– XM9HP7 Ketobemidone ––– XM76M8 Fentanyl –– XM8286 Diphenylpropylamine derivatives ––– XM3246 Dextromoramide ––– XM55Z5 Piritramide ––– XM8GB8 Dextropropoxyphene ––– XM5GN5 Bezitramide –– XM1QE0 Benzomorphan derivatives ––– XM9K14 Pentazocine –– XM09R6 Morphinan derivatives ––– XM1682 Butorphanol ––– XM4P05 Nalbuphine –– XM9Z94 Buprenorphine –– XM02X7 Etorphine –– XM3PK7 Acetorphine –– XM0K66 Phenoperidine –– XM40T9 Meptazinol –– XM0GU8 Drotebanol –– XM7VK6 Loperamide oxide –– XM13Q9 Dezocine –– XM25Z3 Tapentadol –– XM1G85 Oliceridine – XM4PD9 Nalmefene – XM4M74 Difelikefalin – XM05B3 Diamorphine – XM69R4 Morphine, morphine derivatives and metabolites –– XM39E2 14-hydroxydihydro-morphinone –– XM5CY8 Acemorphan –– XM0E25 Benzomorphan –– XM8YM7 Benzyl morphine –– XM0BB1 Blue velvet –– XM45R8 Desomorphine –– XM4T95 Dihydromorphine – XM0VG7 Catha (edulis) (tea) – XM0238 Khat – XM3GQ0 Central nervous system stimulants, not elsewhere classified – XM0854 Cerebral stimulants psychotherapeutic – XM93X4 Cerebral stimulants – XM7125 Stimulant central nervous system psychotherapeutic –– XM6R58 Novocain topical – XM0217 Methitural –– XM6NN7 Nupercaine, spinal XM2XY6 4-Aminobutyric acid –– XM8739 Nupercaine topical –– XM0QU2 Orthocaine –– XM5HP0 Oxetacaine –– XM6V01 Oxethazine –– XM6RN9 Oxybuprocaine –– XM7H65 Percaine, spinal –– XM7EK6 Percaine topical –– XM6Z26 Phenacaine –– XM2ZH3 Piperocaine ––– XM7UW6 Piperocaine infiltration ––– XM8J09 Piperocaine nerve block ––– XM40M8 Piperocaine topical –– XM8AE6 Pitkin's solution –– XM2X66 Prilocaine ––– XM9NH0 Prilocaine infiltration ––– XM85Q7 Prilocaine nerve block –– XM4EE1 Prilocaine regional –– XM5L66 Procaine ––– XM05Z5 Procaine nerve block ––– XM1CG3 Procaine regional ––– XM8KS3 Procaine spinal –– XM97J9 Proparacaine –– XM72A2 Propoxycaine ––– XM9BY7 Propoxycaine infiltration ––– XM2DT4 Propoxycaine nerve block ––– XM0BG4 Propoxycaine topical –– XM87E0 Quotane –– XM2MX6 Stovaine ––– XM79W4 Stovaine infiltration ––– XM08B5 Stovaine nerve block ––– XM9657 Stovaine spinal ––– XM3MW8 Stovaine topical –– XM6392 Surfacaine –– XM1HW1 Tetracaine ––– XM32E4 Tetracaine nerve block ––– XM9H96 Tetracaine regional ––– XM9CQ9 Tetracaine spinal –– XM3QD1 Trimecaine –– XM2FR2 Tronothane –– XM7771 Xylocaine infiltration –– XM18M2 Xylocaine nerve block –– XM5K48 Xylocaine spinal –– XM5G11 Xylocaine topical –– XM1030 Alprazolam –– XM4R58 Bentazepam –– XM2GL0 Benzodiapin –– XM9JC7 Bromazepam –– XM2S43 Brotizolam –– XM5133 Camazepam –– XM9S41 Carpipramine –– XM1J81 Central nervous system depressants benzodiazepines –– XM5JC4 Chlordiazepoxide –– XM43U0 Clobazam –– XM3C29 Dipotassium clorazepate –– XM0A75 Clotiazepam –– XM5M11 Cloxazolam –– XM0GD3 Delorazepam –– XM8P99 Diazepam –– XM9YX9 Estazolam –– XM54N1 Ethyl loflazepate –– XM9DN9 Etizolam –– XM8NC2 Fludiazepam –– XM9W71 Flunitrazepam –– XM73H1 Flurazepam –– XM68Z6 Flutazolam –– XM81V7 Flutoprazepam –– XM3FR2 Halazepam –– XM86G3 Haloxazolam –– XM5WE7 Ketazolam –– XM6KW2 Loprazolam –– XM85H7 Lorazepam –– XM1EE3 Lormetazepam –– XM9KN4 Medazepam –– XM7QC1 Mexazolam –– XM9PG6 Midazolam –– XM8TH1 Nimetazepam –– XM4TR7 Nitrazepam –– XM4FQ9 Nordazepam –– XM1A29 Oxazepam –– XM62U2 Oxazolam –– XM3LR9 Perlapine –– XM0GW7 Pinazepam –– XM4M86 Prazepam –– XM42F4 Quazepam –– XM3215 Temazepam –– XM79N8 Tofisopam –– XM9X46 Tranquilizer benzodiazepine –– XM0G58 Tranxene –– XM1VC3 Triazolam –– XM1YU1 Valium –– XM36R8 Potassium clorazepate –– XM94Z2 Adinazolam –– XM66N4 Doxefazepam –– XM4BU2 Cinolazepam – XM8CM3 Diphenylmethane derivatives –– XM8CV8 Hydroxyzine –– XM70L1 Captodiame – XM96H3 Carbamates –– XM3MX1 Meprobamate –– XM8G67 Emylcamate – XM3XU7 Aldehydes and derivatives –– XM8AH5 Chloral hydrate –– XM8D85 Chloralodol ––– XM0ZC2 Paracetaldehyde –– XM46J8 Acetylglycinamide chloral hydrate –– XM9V32 Dichloralphenazone –– XM0V58 Cinnamaldehyde –– XM37U9 Hexyl cinnamal –– XM5TZ2 Amyl cinnamal –– XM9J50 Butylchloral hydrate – XM6R00 Piperidinedione derivatives –– XM5S80 Glutethimide –– XM2MN1 Methyprylon –– XM2MC9 Pyrithyldione – XM4YG0 Barbiturates and derivatives –– XM3Z73 Narcobarbital –– XM01Z3 Pentobarbital –– XM01F5 Amobarbital –– XM8TB8 Butobarbital –– XM2B90 Barbital –– XM6QG0 Secobarbital –– XM28V1 Talbutal –– XM6NX3 Vinylbital –– XM9VX7 Vinbarbital –– XM89L9 Cyclobarbital –– XM7ZK9 Heptabarbital –– XM8FN0 Allobarbital –– XM8T75 Inhaled anaesthetics –– XM8C15 Proxibarbal ––– XM4VX3 Ethers –– XM60H4 Methylphenobarbital –––– XM3J00 Diethyl ether –– XM2605 Phenobarbital –––– XM7UB3 Vinyl ether –– XM5J41 Primidone ––– XM0TE1 Halogenated hydrocarbons –– XM45T7 Barbexaclone –––– XM2FH0 Halothane –– XM64T5 Metharbital –––– XM7MX5 Chloroform –– XM1ZM1 Reposal ––––– XM1GP5 Chloroform vapor –– XM1WN6 Etallobarbital –––– XM35M6 Enflurane –– XM8YV1 Aprobarbital –––– XM1E91 Trichloroethylene anaesthetic gas –– XM50Q3 Brallobarbital –––– XM9HY9 Isoflurane –– XM3UQ5 Butalbital ––– XM0ZA2 Anaesthesia endotracheal –– XM6XH1 Butallylonal ––– XM05Z8 Anaesthetic gaseous –– XM4C65 Difebarbamate ––– XM8V73 Anaesthetic halogenated hydrocarbon derivatives –– XM8DQ9 Methobarbital, methobarbitone ––– XM5UK1 Central nervous system depressants anaesthetic gases –– XM3YG4 Nealbarbital ––– XM42D4 Chloroform anaesthetic –– XM6F85 Probarbital ––– XM2DK4 Chloroform water, concentrated –– XM37N4 Propallylonal ––– XM9TE3 Divinyl ether –– XM81J9 Secbutabarbital ––– XM3EA4 Ethyl bromide anaesthetic – XM4843 Z-drugs ––– XM2D90 Ethyl chloride anaesthetic –– XM8LM1 Zopiclone ––– XM6WF0 Ethylene anaesthetic –– XM8188 Zolpidem ––– XM9K99 Fluroxene –– XM0UU3 zaleplon ––– XM73B5 Nitrous oxide –– XM4DP1 Eszopiclone ––– XM9NP2 Trifluoroethyl vinyl ether – XM0GA0 Melatonin receptor agonists ––– XM7Q24 Vinesthene –– XM7R38 Melatonin ––– XM1C44 Desflurane –– XM4Y11 Ramelteon ––– XM07G7 Sevoflurane –– XM0DX1 Tasimelteon ––– XM8X62 Xenon –– XM7D47 Intravenous anaesthetics –– XM93J2 Bromide salts ––– XM14F2 Alphadolone –– XM5V35 Acecarbromal ––– XM4PF7 Alfaxalone –– XM3260 Bromisoval ––– XM59B1 Barbiturate anaesthetic, intravenous –– XM7XH5 Bromoform ––– XM9CB4 Brevital sodium –– XM68H5 Carbromal ––– XM6LE6 Buthalitone sodium ––– XM5K69 Butyl thiobarbital sodium –– XM4JD8 Acetylpheneturide ––– XM9SR9 Central nervous system depressants anaesthetic, intravenous –– XM0Y74 Allylisopropylacetylurea ––– XM5MB2 Etomidate –– XM2MT0 Allyltribromide ––– XM93E9 Evipal sodium –– XM0FX2 Ammonium bromide ––– XM5ZF4 Sernyl –– XM2P06 Anticonvulsant hypnotic ––– XM4XN0 Thialbarbital –– XM4LR0 Anticonvulsant pyrimidinedione ––– XM66H8 Thiamylal –– XM80V1 Anticonvulsant specified ––– XM8UK0 Thiamylal sodium –– XM2851 Apronal ––– XM4NL3 Thiobarbital sodium –– XM8WF0 Avomine ––– XM1QW9 Thiobarbiturate anaesthetic –– XM34M8 Beta-Chlor ––– XM72F2 Thiobutabarbital sodium –– XM2S35 Bromal (hydrate) ––– XM7JR4 Methohexital –– XM16D8 Bromine compounds (medicinal) ––– XM08U4 Hexobarbital –– XM0JD2 Bromine sedative ––– XM0EL8 Thiopental sodium –– XM14P7 Bromisovalum ––– XM7C11 Ketamine –– XM0L99 Bromural ––– XM4BS0 Propanidid –– XM7Q19 Calcium bromide ––– XM1903 Propofol –– XM44G1 Bromides ––– XM2W08 Esketamine –– XM6Z70 Central nervous system depressants chloral hydrate –– XM7T11 Cyclopropane –– XM4A26 Central nervous system depressants hypnotics specified –– XM9MS5 Gammahydroxybutyrate –– XM0MP0 Central nervous system depressants paraldehyde –– XM5C03 Hexobarbital rectal –– XM2PX1 Chloral derivative –– XM20X3 Minaxolone –– XM5HQ1 Chloralamide –– XM2MR8 Tiletamine –– XM1XU2 Chloretone –– XM8DR0 Tribromoethanol, rectal –– XM7N56 Chlorhexadol – XM7Y85 Local anaesthetics –– XM7GE6 Clomethiazole –– XM1FJ6 Amylocaine, regional –– XM58S5 Croton chloral ––– XM1H49 Amylocaine, regional infiltration –– XM1L51 Diethylsulfone-diethylmethane ––– XM7CH6 Amylocaine, regional nerve block –– XM5P16 Divalproex ––– XM37J6 Amylocaine, regional spinal –– XM2ML0 Doriden ––– XM5JY6 Amylocaine, regional topical –– XM0YS0 Dormison –– XM5R82 Anaesthesia, caudal –– XM76A5 Ectylurea –– XM8MY3 Anaesthesia, epidural –– XM4SW2 Ethchlorvynol –– XM25C7 Anaesthesia, mucosal –– XM8HM5 Ethinamate –– XM0D14 Anesthesia rectal local –– XM0959 Etifoxine –– XM0FJ3 Anesthesia regional –– XM5084 Hexapropymate –– XM0LM0 Anaesthetic infiltration –– XM3GR8 Hypnotic drug specified –– XM7EC3 Anaesthetic spinal –– XM1H40 Lactuca (virosa) (extract) –– XM8E23 Anesthetic topical –– XM7EA2 Lactucarium –– XM3S41 Anaesthetic with local muscle relaxant –– XM2447 Lettuce opium –– XM5ZK7 Aptocaine –– XM1SJ9 Levanil –– XM52S4 Articaine –– XM9S20 Levoprome –– XM4YN0 Benzamine –– XM3C52 Methaqualone –– XM8KD9 Benzocaine –– XM8UW8 Methyl sulfonal –– XM1604 Betoxycaine –– XM79Y3 Methylpentynol –– XM5YL1 Bupivacaine –– XM9L86 Niaprazine ––– XM7WQ7 Bupivacaine infiltration –– XM67F2 Noludar ––– XM4216 Bupivacaine nerve block –– XM41Z4 Periclor ––– XM46M2 Bupivacaine spinal –– XM7865 Petrichloral –– XM3781 Butacaine –– XM8U36 Phenergan –– XM7MD5 Butamben –– XM3YQ0 Potassium bromide –– XM9VA7 Butanilicaine –– XM23J2 Propionaldehyde (medicinal) –– XM0HA0 Butyl aminobenzoate –– XM5KU5 Quaalude –– XM5NW5 Butyn –– XM5YQ4 Sedative mixed –– XM2YU2 Carbocaine infiltration –– XM53R6 Sedormid –– XM8C65 Carbocaine nerve block –– XM5BF2 Serenesil –– XM2DT1 Carbocaine topical –– XM8SU3 Sodium bromide –– XM6HZ0 Chloroprocaine –– XM9F88 Sodium valproate ––– XM8XD3 Chloroprocaine infiltration –– XM4ZG6 Somnos ––– XM0GC2 Chloroprocaine nerve block –– XM1BT3 Sopor ––– XM94U2 Chloroprocaine spinal –– XM2N03 Soporific drug specified type –– XM0L28 Cinchocaine –– XM81Z5 Sulfonal ––– XM5Y10 Cinchocaine topical –– XM9QV2 Sulfonethylmethane –– XM7FD6 Cyclaine –– XM4YF8 Sulfonmethane –– XM41W7 Cyclomethycaine –– XM8296 Tetronal –– XM3BB4 Dimethocaine –– XM6WP4 Tranquilizer with hypnotic or sedative –– XM8UZ3 Diperodon –– XM9XF5 Tribromacetaldehyde –– XM23R3 Dorsacaine –– XM1DU6 Trichloroethanol –– XM5601 Dyclone –– XM4236 Trichloroethyl phosphate –– XM3QB4 Dyclonine –– XM68E8 Triclofos –– XM20M0 Endocaine –– XM2334 Trional –– XM0P92 EPAB –– XM16S3 Triple bromides –– XM2H77 Ethocaine infiltration –– XM3PP3 Valerian root –– XM6585 Ethocaine nerve block –– XM0MV0 Valerian tincture –– XM7217 Ethocaine spinal –– XM1WZ4 Valmid –– XM1WJ3 Ethyl aminobenzoate –– XM2TP4 Valnoctamide –– XM87H9 Ethyl chloride local anaesthetic –– XM2AQ9 Welldorm –– XM8X57 Etidocaine –– XM1ZF1 Buspirone ––– XM8013 Etidocaine infiltration –– XM01J5 Mephenoxalone ––– XM8RU6 Etidocaine nerve block –– XM9TL2 Propiomazine –– XM2F20 Eucaine –– XM15N4 Sodium oxybate –– XM76M6 Hexylcaine –– XM3EH5 Benzoctamine –– XM5863 Leucinocaine –– XM9727 Gedocarnil –– XM1MK4 Mepivacaine –– XM5928 Fabomotizole ––– XM0EH7 Mepivacaine epidural –– XM4DF5 Lavandulae aetheroleum –– XM9DE9 Meprylcaine –– XM8488 Valerianae radix –– XM7CG8 Metabutethamine –– XM2HN6 Suvorexant –– XM68T6 Nesacaine –– XM2AY7 Dipiperonylaminoethanol ––– XM6AA0 Nesacaine infiltration –– XM9235 Lemborexant ––– XM4148 Nesacaine nerve block – XM1VL2 Hexethal (sodium) –– XM38C9 Novocain infiltration – XM7MG1 Mephebarbital Chemical agent - multiple selections are allowed [select] XM6U34 Alcohol – XM9BA5 Alcohol vapor – XM51N7 Allyl Alcohol – XM6K71 Bay rum – XM0AD5 Benzyl alcohol nonmedicinal – XM7VB3 Cinnamyl alcohol – XM3XS0 Cyclohexanol – XM8ZW3 Ethanol –– XM1A61 Alcohol beverage –– XM8HG4 Absolute alcohol –– XM3094 Denatured alcohol ––– XM6DN6 Ethanol disinfectant –– XM8RP6 Ethanol motor fuel – XM2VC0 Ethyl methylcarbinol – XM48D0 Fusel alcohol –– XM88C8 Amyl alcohol –– XM5JW4 Amylene hydrate –– XM49S0 Butyl alcohol –– XM6HQ5 Diethyl carbinol –– XM5SH0 Isoamyl alcohol –– XM5RS7 Propyl alcohol –– XM5M32 Trimethylcarbinol – XM6C11 Hexahydrocresol – XM4BN8 Hydroabietyl alcohol – XM5531 Isopropyl alcohol –– XM8YA1 Isopropyl rubbing alcohol – XM80Q0 Jamaica ginger – XM7KD9 Methanol –– XM0ZA4 Methanol motor fuel – XM6VD7 Antifreeze, not elsewhere classified – XM7XX5 Canned heat, not elsewhere classified – XM4S45 Geraniol – XM7UN9 Hydroxycitronellal –– XM88J8 Tobacco Associated with - multiple selections are allowed [select] 6C4F.3 Intoxication due to multiple specified psychoactive substances 6C4F.4 Multiple specified psychoactive substances withdrawal – 6C4F.40 Multiple specified psychoactive substances withdrawal, uncomplicated – 6C4F.41 Multiple specified psychoactive substances withdrawal, with perceptual disturbances – 6C4F.42 Multiple specified psychoactive substances withdrawal, with seizures – 6C4F.43 Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures – 6C4F.4Y Other specified multiple specified psychoactive substances withdrawal – 6C4F.4Z Multiple specified psychoactive substances withdrawal, unspecified PB20 Unintentional exposure to or harmful effects of opioids or related analgesics PB21 Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants PB22 Unintentional exposure to or harmful effects of psychostimulants PB23 Unintentional exposure to or harmful effects of cannabinoids or hallucinogens PB24 Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs PB25 Unintentional exposure to or harmful effects of antidepressants PB26 Unintentional exposure to or harmful effects of antipsychotics PB27 Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs PB28 Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance PB29 Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances PB30 Unintentional exposure to or harmful effects of alcohols PB31 Unintentional exposure to or harmful effects of organic solvents PB32 Unintentional exposure to or harmful effects of carbon monoxide PB33 Unintentional exposure to or harmful effects of pesticides PB34 Unintentional exposure to or harmful effects of corrosive substances PB35 Unintentional exposure to or harmful effects of halogen derivatives of aliphatic or aromatic hydrocarbons PB36 Unintentional exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source PC90 Intentional self-harm by exposure to or harmful effects of opioids or related analgesics PC91 Intentional self-harm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants PC92 Intentional self-harm by exposure to or harmful effects of psychostimulants PC93 Intentional self-harm by exposure to or harmful effects of cannabinoids or hallucinogens PC94 Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs PC95 Intentional self-harm by exposure to or harmful effects of antidepressants PC96 Intentional self-harm by exposure to or harmful effects of antipsychotics PC97 Intentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs PC98 Intentional self-harm by exposure to other and unspecified drug, medicament and biological substance PC99 Intentional self-harm by exposure to or harmful effects of multiple drugs, medicaments or biological substances PD00 Intentional self-harm by exposure to or harmful effects of alcohols PD01 Intentional self-harm by exposure to or harmful effects of organic solvents PD02 Intentional self-harm by exposure to or harmful effects of carbon monoxide PD03 Intentional self-harm by exposure to or harmful effects of pesticides PD04 Intentional self-harm by exposure to or harmful effects of corrosive substances PD05 Intentional self-harm by exposure to or harmful effects of other or unspecified substances chiefly nonmedicinal as to source PH40 Exposure to or harmful effects of undetermined intent of opioids or related analgesics PH41 Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants PH42 Exposure to or harmful effects of undetermined intent of psychostimulants PH43 Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens PH44 Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs PH45 Exposure to or harmful effects of undetermined intent of antidepressants PH46 Exposure to or harmful effects of undetermined intent of antipsychotics PH47 Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs – PH47.0 Harmful effects of or exposure to mixed antiepileptics, not elsewhere classified, undetermined intent – PH47.Z Undetermined intent: Harmful effects of and exposure to noxious substances: Drugs, medicaments or biological substances: Unspecified antiepileptics or antiparkinsonism drugs PH48 Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances PH49 Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances PH50 Exposure to or harmful effects of undetermined intent of alcohols PH51 Exposure to or harmful effects of undetermined intent of organic solvents PH52 Exposure to or harmful effects of undetermined intent of carbon monoxide PH53 Exposure to or harmful effects of undetermined intent of pesticides PH54 Exposure to or harmful effects of undetermined intent of corrosive substances PH55 Exposure to or harmful effects of undetermined intent of halogen derivatives of aliphatic or aromatic hydrocarbons PH56 Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use PL01 Complementary or traditional medicines associated with injury or harm in therapeutic use PL01.0 Complementary or traditional medicines associated with injury or harm in therapeutic use, Herbal Preparations or Formulas PL01.1 Complementary or traditional medicines associated with injury or harm in therapeutic use, Dietary Supplements, Vitamins or Minerals PL01.2 Complementary or traditional medicines associated with injury or harm in therapeutic use, Complementary or Traditional Medicines, not elsewhere classified PL01.Y Other specified complementary or traditional medicines associated with injury or harm in therapeutic use PL01.Z Complementary or traditional medicines associated with injury or harm in therapeutic use, unspecified PL0Z Substances associated with injury or harm in therapeutic use, unspecified Has causing condition - a selection is required - multiple selections are allowed [select] 6C4F.0 Episode of harmful use of multiple specified psychoactive substances 6C4F.1 Harmful pattern of use of multiple specified psychoactive substances – 6C4F.10 Harmful pattern of use of multiple specified psychoactive substances, episodic – 6C4F.11 Harmful pattern of use of multiple specified psychoactive substances, continuous – 6C4F.1Z Harmful pattern of use of multiple specified psychoactive substances, unspecified 6C4F.2 Multiple specified psychoactive substances dependence – 6C4F.20 Multiple specified psychoactive substances dependence, current use – 6C4F.21 Multiple specified psychoactive substances dependence, early full remission – 6C4F.22 Multiple specified psychoactive substances dependence, sustained partial remission – 6C4F.23 Multiple specified psychoactive substances dependence, sustained full remission – 6C4F.2Z Multiple specified psychoactive substances dependence, unspecified
synonyms Mood disorder induced by multiple specified psychoactive substances Mood disorder induced by multiple specified psychoactive substances with depressive symptoms Mood disorder induced by multiple specified psychoactive substance with manic symptoms Mood disorder induced by multiple specified psychoactive substance with mixed depressive and manic symptoms
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com